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A noteworthy feature of the compound theophylline is that it forms crystals with a triangular 
habit, an extremely rare phenomenon for an organic molecule. Here, we investigate the 
formation of these crystals, comprised of the polymorph Form II (Pna21), and demonstrate that 
the triangles are obtained from solvents which are highly hydrophobic, or which have a hydrogen 
bond acceptor group and no hydrogen bond donor group. The formation of the triangular crystal 
habit is rationalized on the basis of the way such solvents interact with the inequivalent (001) and 
(00-1) polar crystal faces of Form II. Interactions are significantly stronger at one face than the 
other, inhibiting growth in one direction and limiting crystal growth to a single, triangle shaped, 
growth sector. This rationalization also enabled interesting surface features observed by atomic 
force microscopy to be interpreted. Furthermore, we report a second, previously unreported, type 
of triangular crystal of theophylline for which the angle at the tip of the triangle is obtuse rather 
than acute. These crystals are proposed, with the aid of transmission electron microscopy and 
crystal structure prediction, to be a new polymorphic form of theophylline. 
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A noteworthy feature of the compound theophylline is that it forms crystals with a triangular 
habit, an extremely rare phenomenon for an organic molecule. Here, we investigate the 
formation of these crystals, comprised of the polymorph Form II (Pna21), and demonstrate that 
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(00-1) polar crystal faces of Form II. Interactions are significantly stronger at one face than the 
other, inhibiting growth in one direction and limiting crystal growth to a single, triangle shaped, 
growth sector. This rationalization also enabled interesting surface features observed by atomic 
force microscopy to be interpreted. Furthermore, we report a second, previously unreported, type 
of triangular crystal of theophylline for which the angle at the tip of the triangle is obtuse rather 
than acute. These crystals are proposed, with the aid of transmission electron microscopy and 
crystal structure prediction, to be a new polymorphic form of theophylline. 
 
Introduction 
The large diversity observed in the habits of crystals,
1,2
 ranging from simple cubic blocks to 
the intricate hexagonal structures of snowflakes,
3,4
 results from the complex interplay of the 
many different processes involved in crystal growth.
5-11
 Understanding these phenomena is not 
only of academic importance, but also critical in many industrial sectors since the behavior of 
crystalline materials can be strongly influenced by crystal habit.
12-14
 For example, in many 
applications the shape and size of particles must be carefully controlled to ensure that product 
performance is consistent from batch to batch.
12, 14-16
 Furthermore, while the process of 
generating a desired particle size and morphology profile in a batch of material has traditionally 
been performed post crystallization through techniques such as milling and micronisation,
17, 18
 it 
is more desirable to gain sufficient control of the crystallization step such that crystals with 
optimum characteristics are grown directly.
18-20
 For these reasons, focus has recently been 
directed to gaining further control and understanding of crystallization processes.
21-25
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In addition to morphology, crystallization conditions can also be used to control which crystal 
form (polymorph) of a compound is generated.
26-29
 This is important because the various crystal 
forms a compound may adopt can have very different properties.
17, 30, 31
 While it is still usually 
impossible to say ‘a priori’ which crystal form will result from a given set of crystallization 
conditions,
32 
notable advances have been made in recent years in the prediction of aspects of 
polymorphic behaviour.
33-36
 For example, using crystal structure prediction it is now routinely 
possible to computationally generate plausible crystal structures for a simple organic compound 
and determine which is likely to be the most stable form on the basis of lattice energy 
calculations.
33, 37-39
 An important question, however, is why crystal structure prediction often 
generates many more low energy crystal forms for a compound than are found to exist in 
practice
32, 40
 One possibility is that these forms do exist experimentally, but only in trace 
amounts as minor components of mixtures with other crystal forms, and so are rarely detected.
40
 
An example of such behavior is presented in this study. 
Theophylline is a pharmaceutically active compound used to treat asthma and 
cardiopulmonary disease for which there are six previously reported crystal forms 
(crystallographic data for those forms for which crystal structure determination has been 
performed are given in the Supporting Information, Table S1).
40,
 
41-46
 Form II (orthorhombic, 
space group Pna21), is the most commonly encountered polymorph, and was long believed to be 
the thermodynamic form of theophylline under ambient conditions, though it has recently been 
shown that Form IV is in fact more stable.
47
 The crystal structure of Form II was determined by 
Ebisuzaki et al using crystals grown by sublimation that were reported to have a thin-plate 
morphology. Notably, Form II has subsequently been reported to crystallize with a highly 
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unusual triangular habit, during both supercritical CHF3 crystallization and solution growth from 
nitromethane, though no discussion of the growth mechanism was given.
45, 46
 
In this study, the factors leading to growth of Form II theophylline crystals with a triangular 
habit are elucidated. It is demonstrated that there is a strong influence of solvent on the resulting 
crystal habit, with both solvent polarity and the ability of a solvent to form hydrogen bonding 
interactions contributing to whether or not triangular crystals are obtained. Transmission electron 
microscopy is used to map crystallographic directions to crystal habit allowing the growth of 
triangular crystals to be rationalized on the basis of the arrangement of molecules in the polar 
crystal structure of Form II . The model of triangular crystal growth thus derived is then used to 
interpret interesting growth features on the surfaces of theophylline crystals identified by atomic 
force microscopy. We also present a second type of triangular theophylline crystal which has a 
shape that does not fit this model. It is suggested that these crystals correspond to a new 
polymorph of theophylline, the crystal structure of which is proposed from an analysis of 
electron diffraction data and comparison with a set of putative structures generated 
computationally by global lattice energy searching.  
 
Experimental Section 
All chemicals were purchased from Sigma-Aldrich (purity ≥ 99%) and used without further 
purification. 
Triangular crystals of Form II of theophylline were grown by solution crystallization from a 
variety of solvents including nitromethane, ethyl acetate, dioxane and toluene using either 
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evaporation or cooling to induce supersaturation and crystal growth. The following conditions 
were used to generate samples for analysis by transmission electron microscopy and atomic force 
microscopy and are given as an example: 10.0 mg of theophylline was dissolved in 2.0 ml of 
nitromethane with heating. The resulting solution was then stored at -20 °C to induce 
supersaturation and precipitation. No stirring or solvent evaporation was performed. 
Optical microscopy was performed on a Leica DM1000 instrument with a polarizing filter.  
Transmission electron microscopy (TEM) characterization was performed at room temperature 
on a Philips CM30 instrument operating at 300 kV and data were collected on photographic 
films which were scanned in order to generate digital images. Samples were supported on holey-
carbon films on 300 mesh copper grids held within a double tilt sample holder. The diffraction 
patterns were used for crystal form identification and indexed by comparison with the reported 
crystal structure of Form II of theophylline (CSD ref BAPLOT01)
42
. The positions of reflections 
in experimental diffraction patterns were measured, converted to d-spacings and matched to 
calculated values for the Form II structure. The experimental diffraction patterns were then 
compared with simulated diffraction patterns of the appropriate zone axes to ensure a match 
using CrystalMaker SingleCrystal software. The relative orientations of images and diffraction 
patterns were determined through analysis of crystals of molybdenum trioxide (where the 
relationship between crystal structure and crystal habit is known)
48
. 
Atomic force microscopy (AFM) images were recorded using a Veeco Instruments Multimode 
atomic force microscope, operated by a Nanoscope IIIa controller, interfaced with a Quadrex 
extender module. Samples were prepared on a mica coverslip attached to a stainless steel AFM 
sample disc using a sticky tab and imaged using a J-scanner (150 µm maximum scan size) in 
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contact mode. Data were analyzed using NanoscopeTM software version 6 and images were 
flattened prior to analysis. 
Crystal structure prediction (CSP): Putative crystal structures of theophylline were generated 
with the CrystalPredictor program,
49
 using rigid molecular geometries derived from density 
functional theory calculations on the isolated molecules. Trial crystal structures were created 
with quasi-random unit cell dimensions, molecular positions and orientations with Z' = 1 in 25 
common space groups. The resulting crystal structures were then re-optimized using the 
programs DMACRYS
50
 and CrystalOptimizer,
51
 with intermolecular interactions described by an 
empirically parameterized exp-6 repulsion-dispersion potential (the FIT potential described by 
Coombes et al)
52
 and an atomic multipole electrostatic model, with multipoles derived from a 
distributed multipole analysis
53
 of the calculated molecular charge density. Full details of the 
CSP methodology have been given elsewhere.
54
  
The electrostatic potential surface for theophylline was calculated using the DFT BLYP 
functional
55-57
 and 6-31G(d) basis set as implemented in Tonto
58
 within the software 
CrystalExplorer.
59
 
 
Results and Discussion 
(i) Analysis of the growth of triangular crystals of theophylline 
The growth of triangular crystals of Form II of theophylline by evaporative crystallization 
from a drop of nitromethane solution placed onto a glass slide was followed by optical 
microscopy (Figure 1). The habit adopted by these crystals can be described more accurately as 
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plate-like isosceles triangles which have an acute angle at the vertex. The vertex of the triangle is 
located at the point of nucleation and crystal growth occurs in a direction perpendicular to the 
base of the triangle. It is common for multiple crystals to nucleate at the same nidus and to grow 
out radially. Nucleation can also occur on the faces of existing crystals as highlighted with an 
asterisk in Figure 1c (see also Supporting Information Figure S1), particularly under the high 
supersaturation conditions that are induced by the fast rate of solvent evaporation occurring in 
the glass slide experiment, with the daughter crystals being aligned with the parent suggesting an 
epitaxial relationship. The polymorphic form of the triangular crystals was confirmed to be 
Form II by powder X-ray diffraction (see Supporting Information Figure S2). 
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Figure 1. Optical microscope images showing the growth of triangular crystals of Form II of 
theophylline during evaporation of a small drop of a solution of theophylline in nitromethane 
(placed on a glass slide) over a period of 2 minutes and 15 seconds. The crystals grow in a 
direction from tip to base. The asterisk in image (c) marks a site on the triangular crystal surface 
where nucleation of further crystals of theophylline occurs. 
 
 
The orientation of the theophylline Form II crystal structure was related to the observed 
triangular crystal habit using transmission electron microscopy (ordinarily this mapping could be 
performed using single crystal X-ray diffraction, but as the theophylline crystals prepared in this 
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study were too small to enable such an analysis, having sub-micron thicknesses, TEM was used 
for its combination of high magnification imaging and diffraction capability). A representative 
TEM image of a theophylline crystal is shown in Figure 2 along with a corresponding electron 
diffraction pattern. The b-axis of the crystal runs parallel to the base of the triangular crystals, 
meaning that growth occurs in the [001] direction within a growth sector bounded by the [011] 
and [0-11] directions. The angle between the two edges of the triangle is measured to be 
approximately 47°, which is consistent with the calculated interplanar angle for (011) and (0-11) 
of 48.5°. 
 
 
Figure 2. (a) TEM image showing a triangular plate crystal of Form II of theophylline. The tip 
of the triangle has fractured off prior to analysis,
46
 and there is evidence of uneven growth at the 
rapidly growing crystal face which forms the base of the triangle. (b) Corresponding rotation 
corrected <100> zone axis electron diffraction pattern (signifying that the electron beam was 
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aligned with the a-axis of the crystal when the electron diffraction pattern was recorded). The 
reflections in the diffraction pattern were indexed on the basis of d-spacings and interplanar 
angles, allowing crystallographic directions to be assigned to the TEM image (further details of 
the indexing process are given elsewhere)
46
. 
 
(ii) Solvent dependence of the crystal morphology of theophylline Form II 
The growth of triangular plate-like crystals of theophylline is not limited to crystallization 
from nitromethane. For example, such crystals are also obtained on crystallizing theophylline 
from the solvents ethyl acetate and dioxane (Figures 3a-b). The common feature of these 
solvents is that they possess hydrogen bond acceptor groups, but no donor groups. In addition, 
triangular theophylline crystals can be prepared from highly non-polar solvents such as toluene 
(Figure 3c). Importantly, however, triangular crystals do not always form. For example, solvents 
with both hydrogen bond donor and acceptor groups, such as methanol, ethanol and isopropyl 
alcohol, yield lath shaped crystals (Figures 3d-f). It is notable that crystal growth in these 
alcohols is relatively slow. Furthermore, crystals obtained from chloroform, a molecule with an 
intermediate polarity and no hydrogen bonding capability, are laths with tapered ends (Figure 
3g). Crystallization by sublimation, i.e. in the absence of solvent, leads to the formation of 
rectangular plates (Figure 3h). 
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Figure 3. Polarized light microscopy (PLM) images of crystals of Form II of theophylline 
prepared by solution crystallization from (a) ethyl acetate, (b) dioxane, (c) toluene, (d) methanol, 
(e) ethanol, (f) isopropyl alcohol, (g) chloroform. The crystals were grown by cooling saturated 
solutions of theophylline in the respective solvents and were removed from the crystallization 
solvent prior to analysis. (h) Form II crystals prepared by sublimation. Crystallographic 
directions have been included in images (d) and (g). 
 
 
 14 
(iii) Understanding the growth of triangular theophylline crystals 
The observed solvent dependence of crystal habit was rationalized by considering the crystal 
packing in Form II of theophylline.  
In the Form II structure theophylline molecules assemble through hydrogen bonding 
interactions to form 1D chains (Figure 4a). The chains stack (with parallel rather than antiparallel 
alignment) to give 2D layers as shown in Figures 4b-c. Importantly, hydrogen bonded chains in 
one layer are oriented at 48.5° to those in the next layer, resulting in an ABAB type packing 
arrangement (Figures 4d-e). Furthermore, the polar nature of the Form II structure leads to (001) 
and (00-1) crystal faces being inequivalent. Hydrogen bond donating NH groups are exposed at 
the (100) face (in both A-layers and B-layers) whereas hydrogen bond accepting nitrogen atoms 
possessing a lone pair of electrons (N:) are exposed at (00-1). In contrast, the (010) and (0-10) 
faces are equivalent. 
In the Figures I wonder if the double headed arrows would be better replaced with single-
headed to emphasis the polarity and maybe add A and B to the figure as well as (00-1) and 
(100)? See attachment. 
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Figure 4. (a) An image showing hydrogen bonding between theophylline molecules in the 
crystal structure of Form II of theophylline. The imidazole rings in adjacent theophylline 
molecules are linked through NH
…
N hydrogen bonds to give a linear chain. (b) A single layer of 
theophylline molecules viewed down the a-axis (i.e. the layer is parallel with the plane of the 
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page). Hydrogen bonded chains of theophylline molecules are shown running in the [0-11] 
direction and stacking (through weaker dispersive forces) in the [010] direction in a parallel 
manner. (c) A schematic representation of the layer of molecules shown in (b). The circled NH 
signifies that at the top edge of the layer the theophylline chains are terminated by NH groups 
whereas the circled N: signifies that at the bottom edge chains are terminated by N: groups. (d) 
Image of the full crystal structure of Form II of theophylline viewed down the a-axis. Molecules 
in odd and even numbered layers have been shaded light and dark respectively to highlight the 
difference in the orientations of chains of theophylline molecules in adjacent layers. The chains 
in A-layers run parallel to the <011> axis whereas those in B-layers are parallel to the <0-11> 
axis. (e) A schematic representation of the Form II structure showing the ABAB type stacking 
arrangement of layers (A-layers have been given a textured appearance whereas B-layers have 
been given a smooth appearance). The arrows show the orientations of the chains of molecules in 
each layer. The angle between chains in adjacent layers, as marked with an asterisk, is 48.5°.  
 
The growth rates of different theophylline crystal faces can be related to the Form II structure. 
Firstly, interactions between layers in the Form II structure are weak, leading to a slow growth 
rate at the {100} crystal faces. These faces form the dominant surfaces of all Form II crystals, 
whether triangular plates or rectangular laths. For crystals prepared by sublimation, growth 
would be expected to be to be quickest in the direction parallel the chains of theophylline 
molecules, due to the favorable hydrogen bonding interactions. The fact that this direction is 
different in A and B layers of the Form II structure is a complicating factor, but it is assumed that 
the rate of maximum crystal growth would be in the <001> axis as this lies directly between the 
hydrogen bonding directions in A and B layers.     
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During crystallization from solution, solvent molecules attach to Form II crystal faces and 
influence their growth rates. For example, a solvent capable of forming hydrogen bonds can 
interact with the ends of the growing chains of theophylline molecules, slowing the addition of 
further theophylline molecules and inhibiting the elongation of the chains. Critically, if the 
solvent possesses a hydrogen bond acceptor group, but no donor group (as is the case for 
nitromethane, ethyl acetate and dioxane) this inhibition will occur only at the NH terminated end 
of each theophylline chain. In such a situation, the growth of chains of theophylline molecules in 
A-layers would be inhibited in the [011] direction and occur primarily in the [01-1] direction, 
whereas chains in B-layers would grow primarily in the [0-1-1] direction (Figure 5a). Four 
growth sectors can be defined for theophylline crystals, as shown in Figure 5b, and it follows that 
during crystallization from a hydrogen bond acceptor solvent, the growth of A-layers would be 
inhibited in sectors i and iii, while the growth of B-layers would be inhibited in sectors i and ii. It 
is only within sector iv that the growth of both A-layers and B-layers is favored. Growth will be 
limited to this triangular shaped sector, and this explains why theophylline crystals with a 
triangular habit are observed experimentally. 
Evidence to support this hypothesis for the growth mechanism of triangular crystals of 
theophylline comes from the observation that the crystallographic orientation of sector iv 
matches the crystallographic orientation of experimentally prepared triangular theophylline 
crystals, as determined by TEM (see Figures 2a and 5b). 
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Figure 5. (a) Schematic showing the orientation of hydrogen bonded chains of theophylline 
molecules in A-layers (dashed arrow) and B-layers (solid arrow) in the Form II structure. The 
crosses signify that during crystallization from a solvent with a hydrogen bond acceptor group 
(and no potential hydrogen bond donating group), the growth of chains is inhibited in one 
direction due to interaction of the solvent with the exposed theophylline NH groups. (b) 
Schematic defining four growth sectors for Form II crystals. During crystallization from a 
solvent with a hydrogen bond acceptor group (and no potential hydrogen bond donating group) 
crystal growth is limited to the triangular shaped sector labelled iv. 
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The observation that triangular crystals are also obtained from toluene, despite this solvent 
having no hydrogen bond donor or acceptor groups, indicates that hydrogen bonding is not the 
only factor influencing crystal habit. In this case, the polarity of the solvent is important. As 
shown in Figure 6, the electrostatic potential around theophylline molecules in the Form II 
structure differs strongly in the direction of the polar <001> axis. A strongly lipophilic solvent 
such as toluene will interact more strongly at the (00-1) side of the theophylline molecule (the 
bottom side as displayed in Figure 6) than at the (001) side, leading to inhibition of the growth of 
chains of theophylline molecules at the N: terminated ends. If the previously described model of 
theophylline growth sectors is applied to crystal growth from toluene it can be determined that 
crystal growth will be favored in sector i. The triangular shape of this growth sector matches the 
triangular habit of crystals grown from toluene. 
On crystallizing theophylline from alcohols, solvents which are both hydrogen bond donors 
and acceptors, it would follow that the growth of chains of theophylline molecules would be 
inhibited at both the N: and NH terminated ends, limiting crystal growth in the <001> axis. This 
hypothesis is supported by TEM analysis of lath shaped crystals obtained from methanol, which 
revealed that crystal growth occurred primarily in the <010> axis (Figure 7). This direction is 
associated with the stacking of hydrogen bonded chains of theophylline molecules in both A and 
B layers. The observed slow relative crystal growth rates from alcohol solvents results from 
molecular addition occurring primarily through this stacking, rather than through stronger 
hydrogen bonding interactions. In contrast, chloroform does not interact strongly with either end 
of the hydrogen bonded chains of theophylline molecules because it has no hydrogen bond 
donors or acceptors and is not highly lipophilic. In this case, growth occurs predominantly along 
the <001> axis, as was seen for crystals grown by sublimation.  
 20 
 
Figure 6. Electrostatic potential surface around a molecule of theophylline in the Form II crystal 
structure (calculated from CSD structure BAPLOT01)
42
. The inequivalent (001) and (00-1) 
crystal faces are also shown in the image (edge on). It is evident that the electrostatic potential 
surface of theophylline molecules is significantly more polar at the (001) crystal face than at the 
(00-1) face. 
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Figure 7. (a) TEM image showing a thin lath shaped crystal of Form II of theophylline 
crystallized from methanol. (b) Corresponding rotation corrected <100> zone axis electron 
diffraction pattern. 
 
(iv) Further observations relating to theophylline crystal growth 
It is clear from the above observations that the habit of theophylline Form II crystals is 
strongly influenced by solvent.  Interestingly, there is evidence that habit can also be influenced 
in the solid state. In a previous study, a 1:1 caffeine:theophylline cocrystal was identified and, on 
heating, found to undergo a solid state dissociation wherein the caffeine and theophylline 
molecules separated and recrystallized separately.
60
 The crystal habit of the resulting Form II 
theophylline crystals was plate-like, with shapes ranging between triangles and rectangles. As 
described above, crystallization of theophylline by sublimation yields rectangular plates and it 
might have been expected that the theophylline crystals obtained from the cocrystal dissociation 
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experiment would also have had this habit. The observation that many of the theophylline 
crystals forming after cocrystal dissociation had a triangular character is postulated to be due to 
the interaction of caffeine molecules with the growing theophylline crystal faces. Caffeine is a 
molecule with hydrogen bond acceptor groups, but no donor groups, which means it could 
potentially inhibit elongation at the NH terminated ends of chains of theophylline molecules 
during crystal growth, and thereby influence crystal habit, in much the same way as described 
above for solvents such as nitromethane and ethyl acetate during solution crystallizations. 
Atomic force microscopy analysis of the dominant (100) surface of triangular Form II crystals 
revealed interesting growth features as shown in Figure 8a. The triangular shaped ‘hillocks’ 
evident in the image are regions where the growth of several layers of theophylline molecules 
has initiated at screw dislocations emergent at the crystal surface, and their shape and orientation 
mirror that of the bulk crystal (see Figure 8b). The spiral pattern formed by layers generated at 
the screw dislocations can be seen more clearly in Figure 8c. The triangular appearance of the 
layer growth at these screw dislocations is unusual (emergent screw dislocations typically give 
rise to a symmetrical pattern of layers around the dislocation)
61-65
 and can again be explained by 
the action of the solvent in inhibiting the elongation of chains of theophylline molecules at the 
NH terminated ends. Furthermore, the ABAB type arrangement of layers of molecules in the 
Form II structure is evident in the surface topology. All surface layers originating at the screw 
dislocations have expanded in the direction of the base of the triangle, within a triangular shaped 
growth sector, but growth towards the edge that runs parallel to <011> is slightly faster for 
A-layers than B-layers (in fact growth of A-layers in this direction seems to be limited by the 
extent of growth of the B-layers below) and growth towards the edge that runs parallel to <0-11> 
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is slightly faster for B-layers than A-layers. This leads to an alternating pattern in the appearance 
of layers at theophylline surfaces as shown in the inset of Figure 8a. 
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Figure 8. (a) AFM deflection image of the (100) surface of a crystal of Form II of theophylline 
crystallized from nitromethane (recorded in contact mode). The image shows a region where two 
screw dislocations are emergent at the crystal surface (circled). Several layers of theophylline 
molecules have grown at each of the screw dislocations, the edges of which can be seen as lines 
on the image, resulting in triangular shaped screw dislocation hillocks. The layers have heights 
of approximately 1.2 nm, consistent with the spacing between molecules in the [100] direction 
(A figure showing the layers in the crystal structure of theophylline is included in the Supporting 
Information (Figure S3)). It is evident that there is a slight difference in the way that adjacent 
layers of molecules grow from the screw dislocations. In general, all layers can be seen to grow 
in the direction of the base of the triangle, but the A-layers have grown preferentially to one side 
of the triangle (in the direction of the top left of the image) and the B-layers have grown 
preferentially to the other side (in the direction of the bottom right of the image), as shown 
schematically in the inset. (b) A corresponding optical image showing the whole of the crystal 
(the tip of the crystal has fractured off prior to analysis)
46
. It is apparent that the triangular shaped 
screw dislocation hillocks are aligned with the triangular morphology of the crystal under 
analysis. The dark feature on the right hand side of the image is the AFM cantilever. (c) AFM 
deflection image of the (100) surface of a second theophylline crystal showing the spiral nature 
of layer growth at a screw dislocation. 
 
(v) Evidence for a new polymorphic form of theophylline 
During this study, theophylline has been observed to crystallize with a second type of 
triangular morphology clearly distinguishable from the triangular habit described above. This 
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new variety of triangular crystal possesses a wider growth angle, as shown in Figures 9a and 9b, 
and can be categorized as an obtuse isosceles form. The wide triangles have been obtained from 
both nitromethane and ethyl acetate, but are observed infrequently, approximately once in every 
20 crystallizations, and always occur concomitantly with the conventional triangular crystals of 
Form II, never forming more than a small percentage (< 1 %) of any sample. As a result, 
crystallographic and spectroscopic information could not be obtained from these crystals using 
standard approaches, but it was possible to analyze individual crystals by TEM. The electron 
diffraction pattern in Figure 9c, recorded from one such crystal, is consistent with diffraction 
from the <1-20> zone axis of Form II of theophylline. Interestingly, however, when 
crystallographic directions are mapped onto the crystal it is evident that the [010] 
crystallographic direction runs from tip to base and the base of the triangle is approximately 
parallel with the [001] direction. This is opposite to what was found for the conventional 
triangular crystals described previously. Additionally, crystal defects (which are identified from 
the distortions to bend contours that occur in the vicinity of the defects) can be seen running 
from tip to base in this crystal. In contrast, defects in conventional triangular crystals of Form II 
have been reported to run parallel to the base of the triangles.
46
 Furthermore, the model for 
crystallization of theophylline from a hydrogen bond acceptor solvent described above and 
shown in Figure 5 cannot explain the growth of obtuse triangular crystals. On the basis of these 
observations it is postulated that the obtuse triangular crystals are in fact a new crystal form of 
theophylline.  
It is striking that the wide triangular crystal of theophylline shown in Figure 9b is similar in 
shape to the growth sectors labelled ii and iii in Figure 5b. As described above, the growth of 
Form II is not favored in these sectors during solution crystallization from a hydrogen bond 
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acceptor solvent such as nitromethane. If, however, each of the A-layers were to be rotated by 
180°, so that N: groups are exposed at the (001) and NH groups exposed at the (00-1) face, this 
would give a hypothetical theophylline crystal form which would be expected to grow primarily 
in growth sector ii, and therefore to crystallize as wide triangles (Figure 9d).  
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Figure 9. (a) PLM image of a small selection of theophylline crystals within a sample grown 
from ethyl acetate. Several of the crystals resemble obtuse isosceles triangles rather than the 
acute isosceles triangles described earlier. (b) TEM image of an obtuse triangular crystal of 
theophylline grown from nitromethane. The angle between the two equivalent edges of this 
triangular crystal is approximately 130°. (c) Corresponding rotation corrected electron diffraction 
pattern (recorded from the region highlighted with a circle in the TEM image). Reflections have 
been indexed on the basis that diffraction was from the <1-20> zone axis of Form II of 
theophylline (crystallographic directions were added to image (b) on this basis also). (d) A model 
of a hypothetical crystal form of theophylline which would be expected to crystallize as obtuse 
triangular crystals (within the growth sector marked with an asterisk) from a hydrogen bond 
acceptor solvent (note that the functional groups at the ends of the dashed arrow are reversed in 
comparison to the similar schematic for Form II in Figure 5a). 
 
An ensemble of putative crystal structures of theophylline was generated using crystal 
structure prediction (CSP) calculations and analyzed in an attempt to identify a crystal structure 
which is consistent with the model for the growth of obtuse triangular crystals shown in 
Figure 9d. Such a structure was identified and was found to be that with the 14
th
 lowest lattice 
energy within the ensemble (Figure 10a). This structure has a calculated energy 5.9 kJ.mol
-1
 
greater than Form II, an energy difference which is consistent with systems where polymorphism 
has been observed.
66-69
 It should be noted that the electron diffraction pattern in Figure 8c, which 
was recorded from an obtuse triangular crystal, is consistent with both CSP structure #14 and 
Form II (diffraction from the <10-2> zone axis or <1-20> zone axis respectively), but the 
positions of reflections are closer to that expected for diffraction from CSP structure #14. These 
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results provide support to the hypothesis that the wide triangles are a new crystal form of 
theophylline. This would correspond to the seventh polymorph to be isolated to date and will be 
referred to hereafter as Form VII.  
The arrangement of molecules in the crystal structure of Form VII of theophylline is shown in 
Figure 10b, and is closely related to that in Form II. The primary difference between the two 
forms is the relative orientations of hydrogen bonded chains in the A and B layers (see also the 
schematic in Figure 10c). Form VII crystallizes in the same space group as Form II, Pna21, and 
is calculated to have similar lattice parameters (a = 26.597 Å, b = 8.707 Å, c = 3.876 Å for Form 
VII, cf. a = 24.612 Å, b = 3.830 Å, c = 8.501 Å for Form II). The higher energy of Form VII 
stems partly from less favorable electrostatic interactions between hydrogen bonded chains 
(accounting for 3.1 kJ.mol
-1
 of the energy difference) and partly from poorer packing efficiency 
(resulting in a smaller stabilizing dispersion contribution to the lattice energy), and provides an 
explanation for why this phase is observed so infrequently in comparison to Form II. 
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Figure 10. (a) The results of crystal structure prediction with theophylline. The 73 low energy 
putative structures within 15 kJ.mol
-1
 of the global minimum are plotted by lattice energy and 
density. The computationally derived crystal structure which corresponds to Form II, #2, and that 
which fits observations of wide triangular crystals of theophylline, #14, are highlighted. (b) The 
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crystal structure of CSP structure #14/Form VII of theophylline viewed down the a-axis. (c) A 
schematic representation of the Form VII structure showing the ABAB type stacking 
arrangement of layers (A-layers have been given a textured appearance, whereas B-layers have 
been given a smooth appearance). The arrows show the orientations of hydrogen bonded chains 
of theophylline molecules in each layer. Note that the chains in A-layers are rotated by 180° with 
respect to equivalent chains in the Form II structure. 
 
Conclusions 
Form II of theophylline has been shown to form a triangular crystal habit when crystallized 
from hydrogen bond accepter solvents and highly hydrophilic solvents due to solvent induced 
inhibition of crystal growth in all but one growth sector. Two key structural features which 
enable Form II to grow as triangular crystals have been identified: the presence of a polar axis 
and an ABAB type arrangement of layers wherein the A and B layers are neither parallel nor 
orthogonal. It is postulated that crystal forms of other compounds which share these 
characteristics may also form triangular crystals under the right conditions.  
A second, obtuse triangular crystal morphology has been identified for theophylline, and the 
combination of TEM analysis and crystal structure prediction provided evidence that these wide 
triangular crystals are a new polymorphic form of theophylline. This new polymorph is observed 
rarely, and only as a minor phase in mixtures with Form II, which is likely to be why it has not 
been identified previously. The use of TEM was a critical part of this study, enabling the 
mapping of crystal structure to crystal habit in theophylline Form II crystallites and allowing 
individual crystals of the new theophylline polymorph to be characterized. This is the second 
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time that the combination of TEM and crystal structure prediction has been used to identify a 
crystal structure for a metastable polymorph of theophylline (present as a minor phase in a 
mixture with Form II).
40
 This combination of techniques could prove to be a valuable tool for 
investigating the polymorphic behavior of other compounds, particularly for the analysis of trace 
polymorphic impurities whose presence may be undetected by more common analytical 
methods.  
The observations reported here lend weight to the idea that more, if not most, of the 
computationally predicted low energy crystal structures for a compound can be observed 
experimentally under the right crystallization conditions and with the use of appropriate 
analytical tools. 
 
ASSOCIATED CONTENT 
Supporting Information. Additional optical micrographs of the growth of theophylline Form II 
crystals, a PXRD diffractogram of triangular theophylline crystals and a diagram showing the 
nature of height changes at the (100) theophylline crystal surface are supplied as Supporting 
Information. This material is available free of charge via the Internet at http://pubs.acs.org. 
 
ACKNOWLEDGMENT 
The authors thank the Royal Society, the Pfizer Institute for Pharmaceutical Materials Science 
and the EU INTERREG IVA 2 Mers-Seas-Zeeën Cross-border Cooperation Programme for 
 32 
funding. Prof. K. J. Roberts is gratefully acknowledged for useful discussions on the growth of 
polar crystals. 
 
 
REFERENCES 
 
(1) Groth, P. H. R., Chemische Kristallographie. Erster Teile; W. Englelemann: Leipzig, 
1906. 
(2) Sunagawa, I., Morphology of Crystals, Parts A and B; Terra Science Publishers: Tokyo, 
1989. 
(3) Bentley, W. A.; Humphreys, W. J., Snow Crystals; Dover Publications: USA, 1962. 
(4) Bentley, W. A., Conical Snow. Science 1932, 75, 383. 
(5) Eddleston, M. D.; Jones, W. Cryst. Growth Des. 2010, 10, 365-370. 
(6) Nanev, C. N. Crystallogr. Rev. 1994, 4, 3-71. 
(7) Myerson, A. S. Handbook of Industrial Crystallization. Second edition; Butterworth-
Heinemann: United States, 2002. 
(8) Bailey, M.; Hallett, J. J. Atmos. Sci. 2004, 61, 514–544. 
(9) Dhanaraj, G.; Byrappa, K.; Prasad, V.; Dudley, M., Springer Handbook of Crystal 
Growth; Springer-Verlag: Germany, 2010. 
(10) Wells, A. F. Philos. Mag. 1946, 37, 184-99. 
 33 
(11) Hartman, I. P.; Perdok, W. G. Acta Crystallogr. 1955, 8, 49-52. 
(12) Tiwari, A. K., Crystal Habit Changes and Dosage Form Performance. In Encyclopedia of 
Pharmaceutical Technology, Third edition; Swarbrick, J., Ed.; Informa Healthcare: New York, 
USA, 2006; pp 820-833. 
(13) Bandyopadhyay, R.; Grant, D. J. W. Pharm. Dev. Technol. 2000, 5, 27-37. 
(14) Calderon De Anda, J.; Wang, X. Z.; Lai, X.; Roberts, K. J. J. Process Control 2005, 15, 
785-797. 
(15) Sun, Z.; Ya, N.; Adams, R. C.; Fang, F. S. Am. Pharm. Rev. 2010, 13, (4). 
(16) Mirza, S.; Miroshnyk, I.; Heinamaki, J.; Antikainen, O.; Rantanen, J.; Vuorela, P.; 
Vuorela, H.; Yliruusi, J. AAPS PharmSciTech 2009, 10, 113-119. 
(17) Lee, A. Y.; Myerson, A. S. MRS Bull. 2006, 31, 881-886. 
(18) Rasenack, N.; Steckel, H.; Mueller, B. W. Powder Technol. 2004, 143-144, 291-296. 
(19) Chow, A. H. L.; Tong, H. H. Y.; Chattopadhyay, P.; Shekunov, B. Y. Pharm. Res. 2007, 
24, 411-437. 
(20) Kawashima, Y. Arch. Pharmacal Res. 1984, 7, 145-51. 
(21) For example, the UK funding body EPSRC launched a Grand Challenge in 2009 titled 
'Directed Assembly of Extended Structures with Targeted Properties'. 
(22) Thomas, L. H.; Wales, C.; Zhao, L.; Wilson, C. C. Cryst. Growth Des. 2011, 11, 1450-
1452. 
 34 
(23) Brown, C. J.; Ni, X.-W. CrystEngComm 2012, 14, 2944-2949. 
(24) Zhao, L.; Raval, V.; Briggs, N. E. B.; Bhardwaj, R. M.; McGlone, T.; Oswald, I. D. H.; 
Florence, A. J. CrystEngComm 2014, 16, 5769-5780. 
(25) Wittering, K.; King, J.; Thomas, L. H.; Wilson, C. C. Crystals 2014, 4, 123-140. 
(26) Miller, J. M.; Rodriguez-Hornedo, N.; Blackburn, A. C.; Macikenas, D.; Collman, B. M. 
Biotech. Pharm. Aspect. 2007, 6, 53-109. 
(27) Threlfall, T. Org. Process Res. Dev. 2000, 4, 384-390. 
(28) Bernstein, J., Crystal Polymorphism. In Engineering of Crystalline Materials Properties, 
Novoa, J. J.; Braga, D.; Addadi, L., Eds.; Springer: Dordrecht, The Netherlands, 2008; pp 87-
109. 
(29) Byrn, S.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharm. Res. 1995, 12, 
945-54. 
(30) Singhal, D.; Curatolo, W. Adv. Drug Delivery Rev. 2004, 56, 335-347. 
(31) Blagden, N.; de Matas, M.; Gavan, P. T.; York, P. Adv. Drug Delivery Rev. 2007, 59, 
617-630. 
(32) Price, S. L. Acta Crystallogr., Sect. B Struct. Sci. 2013, 69, 313-328. 
(33) Day, G. M. Crystallogr. Rev. 2011, 17, 3-52. 
(34) Galek, P. T. A.; Fábián, L.; Motherwell, W. D. S.; Allen, F. H.; Feeder, N. Acta 
Crystallogr., Sect. B Struct. Sci. 2007, B63, 768-782. 
 35 
(35) Galek, P. T. A.; Allen, F. H.; Fábián, L.; Feeder, N. CrystEngComm 2009, 11, 2634-
2639. 
(36) Vippagunta, S. R.; Brittain, H. G.; Grant, D. J. Adv. Drug Delivery Rev. 2001, 48, 3-26. 
(37) Day, G. M.; Cooper, T. G.; Cruz-Cabeza, A. J.; Hejczyk, K. E.; Ammon, H. L.; 
Boerrigter, S. X. M.; Tan, J. S.; Della Valle, R. G.; Venuti, E.; Jose, J.; Gadre, S. R.; Desiraju, G. 
R.; Thakur, T. S.; van Eijck, B. P.; Facelli, J. C.; Bazterra, V. E.; Ferraro, M. B.; Hofmann, D. 
W. M.; Neumann, M. A.; Leusen, F. J. J.; Kendrick, J.; Price, S. L.; Misquitta, A. J.; 
Karamertzanis, P. G.; Welch, G. W. A.; Scheraga, H. A.; Arnautova, Y. A.; Schmidt, M. U.; van 
de Streek, J.; Wolf, A. K.; Schweizer, B. Acta Cryst., Sect. B: Struct. Sci. 2009, B65, 107-125. 
(38) Price, S. L. Accounts Chem. Res. 2009, 42, 117-126. 
(39) Neumann, M. A.; Leusen, F. J. J.; Kendrick, J. Angew. Chem., Int. Ed. 2008, 47, 2427-
2430. 
(40) Eddleston, M. D.; Hejczyk, K. E.; Bithell, E. G.; Day, G. M.; Jones, W. Chem.  Eur. J. 
2013, 19, 7883-7888. 
(41) Fucke, K.; McIntyre, G. J.; Wilkinson, C.; Henry, M.; Howard, J. A. K.; Steed, J. W. 
Cryst. Growth Des. 2012, 12, 1395-1401. 
(42) Ebisuzaki, Y.; Boyle, P. D.; Smith, J. A. Acta Crystallogr., Sect. C Cryst. Struct. 
Commun. 1997, C53, 777-779. 
(43) Phadnis, N. V.; Suryanarayanan, R. J. Pharm. Sci. 1997, 86, 1256-63. 
 36 
(44) Khamar, D.; Pritchard, R. G.; Bradshaw, I. J.; Hutcheon, G. A.; Seton, L. Acta 
Crystallogr., Sect. C Cryst. Struct. Commun. 2011, C67, 496-499. 
(45) Roy, C.; Vega-Gonzalez, A.; Subra-Paternault, P. Int. J. Pharm. 2007, 343, 79-89. 
(46) Eddleston, M. D.; Bithell, E. G.; Jones, W. J. Pharm. Sci. 2010, 99, 4072-4083. 
(47) Seton, L.; Khamar, D.; Bradshaw, I. J.; Hutcheon, G. A. Crystal Growth & Design 2010, 
10, 3879-3886. 
(48) Fultz, B.; Howe, J. M., Transmission Electron Microscopy and Diffractometry of 
Materials. Fourth edition; Springer: Berlin Heidelberg, 2013; p 784. 
(49) Karamertzanis, P. G.; Pantelides, C. C. J. Comput. Chem. 2004, 26, 304-324. 
(50) Price, S. L.; Leslie, M.; Welch, G. W. A.; Habgood, M.; Price, L. S.; Karamertzanis, P. 
G.; Day, G. M. Phys. Chem. Chem. Phys. 2010, 12, 8478-8490. 
(51) Kazantsev, A. V.; Karamertzanis, P. G.; Adjiman, C. S.; Pantelides, C. C. J. Chem. 
Theory Comput. 2011, 7, 1998-2016. 
(52) Coombes, D. S.; Price, S. L.; Willock, D. J.; Leslie, M. J. Phys. Chem. 1996, 100, 7352-
60. 
(53) Stone, A. J.; Alderton, M. Mol. Phys. 1985, 56, 1047-64. 
(54) Eddleston, M. D.; Hejczyk, K. E.; Bithell, E. G.; Day, G. M.; Jones, W. Chem. Eur. J. 
2013, 19, 7874-7882. 
(55) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B Condens. Matter 1988, 37, 785-9. 
 37 
(56) Becke, A. D. Phys. Rev. A Gen. Phys. 1988, 38, 3098-100. 
(57) Miehlich, B.; Savin, A.; Stoll, H.; Preuss, H. Chem. Phys. Lett. 1989, 157, 200-6. 
(58) Jayatilaka, D.; Grimwood, D. J., Tonto: A Fortran Based Object-Oriented System for 
Quantum Chemistry and Crystallography. In Computational Science - ICCS 2003, Sloot, P. M. 
A.; Abramson, D.; Bogdanov, A. V.; Gorbachev, Y. E.; Dongarra, J. J.; Zomaya, A. Y., Eds. 
Springer: Berlin Heidelberg, 2003; pp 142-151. 
(59) Spackman, M. A.; McKinnon, J. J.; Jayatilaka, D. CrystEngComm 2008, 10, 377-388. 
(60) Eddleston, M. D.; Lloyd, G. O.; Jones, W. Chem. Commun. 2012, 48, 8075-8077. 
(61) Burton, W. K.; Cabrera, N.; Frank, F. C. Nature 1949, 163, 398-9. 
(62) Verma, A. R. Nature 1951, 167, 939. 
(63) Amelinckx, S. Nature 1951, 167, 939-40. 
(64) Ward, M. D. Chem. Rev. 2001, 101, 1697-1725. 
(65) Rimer, J. D.; An, Z.; Zhu, Z.; Lee, M. H.; Goldfarb, D. S.; Wesson, J. A.; Ward, M. D. 
Science 2010, 330, 337-341. 
(66) Beyer, T.; Day, G. M.; Price, S. L. J. Am. Chem. Soc. 2001, 123, 5086-5094. 
(67) Bernstein, J., Polymorphism in Molecular Crystals; Oxford University Press: United 
States, 2002; p 410. 
(68) Day, G. M.; Motherwell, W. D. S.; Jones, W. Cryst. Growth Des. 2005, 5, 1023-1033. 
 38 
(69) Gavezzotti, A.; Filippini, G. J. Am. Chem. Soc. 1995, 117, 12299-305. 
 
 
 39 
For Table of Contents Use Only.  
 
 
The polar nature of the theophylline Form II crystal structure leads to the growth of triangular 
crystals from hydrophobic solvents and solvents that act as hydrogen bond acceptors, but not 
donors. A second, wider, triangular crystal habit is also occasionally observed and interpreted as 
a new polymorphic form of theophylline, Form VII. This study utilized transmission electron 
microscopy and crystal structure prediction. 
